Furthermore, an elevated expression of EZH2, a methyltransferase subunit of the PRC2 complex, has been shown to be associated with advanced stages of ovarian cancer and to be independently associated with shorter overall survival in ovarian cancer patients [112]. The gene discussed is EZH2; the disease is ovarian cancer.